This study evaluated the antibody immune response in symptomatic and asymptomatic RT–PCR-confirmed COVID-19 patients using different CE-marked IgM and IgG ELISA kits coated with different SARS-CoV-2 antigens. The gene discussed is CD40LG; the disease is COVID-19.